Higher levels of a metabolite called trimethylamine N-oxide (TMAO), produced by bacteria in the gut flora, are associated with an increased risk of heart failure.
Author and source information
This text is consistent with the requirements of medical literature, medical guidelines, and current studies and has been reviewed by medical professionals.
sources:
- WH Wilson Tang, Rosen N Lemaitre, Paul N Jensen, Meng Wang, Zhenning Wang, et al.: Trimethylamine N-oxide and gut microbiota-derived metabolites and the development of incident heart failure in populations; in: Circulation: Heart Failure (published August 9, 2024), Circulation: Heart failure
- Cleveland Clinic: Study by Cleveland Clinic, Tufts University highlights potential of using TMAO—a product of gut microbes—to predict heart failure risk (published August 13, 2024), Cleveland Clinic
Important Note:
This article contains general advice only and should not be used for self-diagnosis or treatment. It cannot replace a visit to your doctor.
Sylvia Plath writes for Social Post News, covering news, politics, business, technology, sport, entertainment, and lifestyle. She focuses on clear, reliable reporting and useful information, helping readers stay informed about current events, emerging trends, and stories that matter.
More Stories
Bumblebees Show Problem-Solving Skills Once Thought Limited to Larger-Brained Animals
Artemis 2’s Orion Heat Shield Faces Critical Test as Astronauts Prepare for Fiery Earth Reentry
Coral Seeding: Artificial Insemination Makes Coral More Heat Tolerant